Europe is home to many of the biggest pharma companies and the best academic biomedical researchers. But the US is the dominant place with thriving hubs of biotech entrepreneurs, people taking big risk and creating much of the value in healthcare. Quite a few countries aspire to create their own dynamic clusters like Boston and San Francisco, but haven’t pulled it off. What is happening today in various European hotspots, at the intersection of academia and entrepreneurship?
Moderator: Luke Timmerman – Timmerman Report
- Divya Chadha Manek – NIHR
- Alexander Mayweg – Versant Ventures
- Antoine Papiernik – Sofinnova Partners
- Issi Rozen – Broad Institute